Samlyn Capital’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-1,954,175
| Closed | -$105M | – | 131 |
|
|
2016
Q1 | $105M | Buy |
1,954,175
+305,662
| +19% | +$16.4M | 2.25% | 7 |
|
|
2015
Q4 | $108M | Sell |
1,648,513
-882,487
| -35% | -$57.9M | 2.24% | 14 |
|
|
2015
Q3 | $143M | Buy |
2,531,000
+398,840
| +19% | +$22.5M | 2.62% | 6 |
|
|
2015
Q2 | $126M | Buy |
2,132,160
+310,760
| +17% | +$18.4M | 2% | 11 |
|
|
2015
Q1 | $113M | Buy |
1,821,400
+123,900
| +7% | +$7.72M | 1.82% | 18 |
|
|
2014
Q4 | $97.6M | Buy |
1,697,500
+630,800
| +59% | +$36.3M | 1.7% | 17 |
|
|
2014
Q3 | $57.3M | Buy |
1,066,700
+296,700
| +39% | +$15.9M | 1.18% | 41 |
|
|
2014
Q2 | $40.4M | Buy |
+770,000
| New | +$40.4M | 0.92% | 50 |
|